Immunovia Completes Discovery Phase for Next-Gen Pancreatic Cancer Test
Immunovia, a company focused on pancreatic cancer detection, successfully completed of the discovery phase of its next-generation test.
Read More
Search Results for: pancreatic adenocarcinoma
PDACatch an FDA Breakthrough Device for Pancreatic Cancer Detection
Singlera Genomics’ PDACatch assay is a novel DNA methylation-based liquid biopsy assay for the detection of pancreatic adenocarcinoma in individuals at high risk for the disease.
Read More
New Genetic Culprit Suspected of Pancreatic Cancer Onset
New research points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer.
Read More
Researchers Discover Molecular Switch in Pancreatic Cancer that Triggers Metastasis
Pancreatic ductal adenocarcinoma affects more than 90% of patients with pancreatic cancer and has an average 5-year survival rate under 10%.
Read More
Stool Sample Microorganisms Could Help Detect Pancreatic Cancer Early
Researchers have found a molecular signature in stool samples that could predict whether patients are at high risk of pancreatic cancer.
Read More